Bliss Infusions And Surgicles Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 40 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 9.90 M
- Revenue Growth 25.22%
- Profit Growth 71.00%
- Ebitda 58.10%
- Net Worth 52.28%
- Total Assets 14.61%
About Bliss Infusions And Surgicles
Bliss Infusions And Surgicles Private Limited (BIASPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 23 November 1984 and has a history of 40 years and two months. Its registered office is in Nashik, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹9.90 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajgopal Mundada and Sagar Mundada serve as directors at the Company.
Company Details
-
Location
Nashik, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24200MH1984PTC034621
-
Company No.
034621
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Nov 1984
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Bliss Infusions And Surgicles Private Limited offer?
Bliss Infusions And Surgicles Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Anti Ulcer Drugs, Anti Infective Drugs & Medicines, Antibiotic Injection.
Who are the key members and board of directors at Bliss Infusions And Surgicles?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sagar Mundada
|
Director | 07-Jul-2021 | Current |
|
Rajgopal Mundada
|
Director | 23-Nov-1984 | Current |
Financial Performance of Bliss Infusions And Surgicles.
Bliss Infusions And Surgicles Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 25.22% increase. The company also saw a substantial improvement in profitability, with a 71% increase in profit. The company's net worth Soared by an impressive increase of 52.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bliss Infusions And Surgicles?
Unlock access to Bliss Infusions And Surgicles's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0
₹9.90 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.99 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Mar 2020 | Hdfc Bank Limited | ₹9.90 M | Satisfied |
How Many Employees Work at Bliss Infusions And Surgicles?
Bliss Infusions And Surgicles has a workforce of 3 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bliss Infusions And Surgicles, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bliss Infusions And Surgicles's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
